These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9989198)

  • 1. [Post-menopausal hormone substitution and ischemic heart disease].
    Sørensen MB; Skouby SO; Ottesen BS
    Ugeskr Laeger; 1999 Feb; 161(5):607-8. PubMed ID: 9989198
    [No Abstract]   [Full Text] [Related]  

  • 2. Postmenopausal hormone therapy offers no protection against heart attacks.
    American Medical Association
    Ginecol Obstet Mex; 2002 Aug; 70():404-5. PubMed ID: 12448045
    [No Abstract]   [Full Text] [Related]  

  • 3. Balancing between observational studies and randomized trials in prevention of coronary heart disease by estrogen replacement: HERS study was no revolution.
    Ylikorkala O
    Acta Obstet Gynecol Scand; 2000 Dec; 79(12):1029-36. PubMed ID: 11130082
    [No Abstract]   [Full Text] [Related]  

  • 4. Health risks outweigh benefits for combined estrogen plus progestin. Clinical trial stopped early in major study.
    American Medical Association
    Ginecol Obstet Mex; 2002 Aug; 70():411-2. PubMed ID: 12449905
    [No Abstract]   [Full Text] [Related]  

  • 5. [Favorable effects of menopausal hormone substitution therapy on risk factors for ischemic heart disease].
    van der Mooren MJ; Merkus JM
    Ned Tijdschr Geneeskd; 1996 Jun; 140(25):1328-9. PubMed ID: 8710016
    [No Abstract]   [Full Text] [Related]  

  • 6. HRT: forever or never?
    Corson SL
    Int J Fertil Womens Med; 2002; 47(4):150-1. PubMed ID: 12199410
    [No Abstract]   [Full Text] [Related]  

  • 7. [Positive effects of estrogens on cardiovascular health].
    Fried G
    Lakartidningen; 2002 May; 99(18):2066-7. PubMed ID: 12082786
    [No Abstract]   [Full Text] [Related]  

  • 8. [After the early termination of the Women's Health Initiative study. New American recommendations for postmenopausal hormone therapy].
    Stjernquist M;
    Lakartidningen; 2003 May; 100(20):1790-7. PubMed ID: 12806859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hormone replacement therapy in menopause and cardiovascular disease].
    Pedersen AT; Skouby SO; Jespersen J; Ottesen BS
    Ugeskr Laeger; 2002 Aug; 164(34):3973-4. PubMed ID: 12212481
    [No Abstract]   [Full Text] [Related]  

  • 10. The Heart and Estrogen/Progestin Replacement Study (HERS) in perspective--results not very surprising.
    Naessen T
    Acta Obstet Gynecol Scand; 2000 Dec; 79(12):1037-41. PubMed ID: 11130083
    [No Abstract]   [Full Text] [Related]  

  • 11. Research update on hormone replacement therapy, heart disease, and women.
    Kennington AK
    Nurse Pract; 1994 May; 19(5):6, 8. PubMed ID: 8065651
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment with estrogen].
    Ingelman-Sundberg A
    Lakartidningen; 2002 Nov; 99(47):4777-8. PubMed ID: 12523062
    [No Abstract]   [Full Text] [Related]  

  • 13. [Conjugated estrogen-gestagen does not reduce cardiovascular morbidity. Were these findings (in the Women's Health Initiative study) really unexpected?].
    Henriksson P
    Lakartidningen; 2002 Nov; 99(47):4716-9. PubMed ID: 12523045
    [No Abstract]   [Full Text] [Related]  

  • 14. The Women's Health Initiative estrogen plus progestin trial: the study and how it changes our practice.
    Hendrix SL
    J Am Osteopath Assoc; 2003 Feb; 103(2 Suppl 2):S3-5. PubMed ID: 12625631
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hormone replacement therapy in menopause and cardiovascular disease--one more time].
    Os I; Tonstad S
    Tidsskr Nor Laegeforen; 2002 Aug; 122(18):1808-10. PubMed ID: 12362695
    [No Abstract]   [Full Text] [Related]  

  • 16. Hormone replacement therapy and risk of heart disease.
    Elliott KK
    Am Fam Physician; 1999 Nov; 60(8):2234, 2237. PubMed ID: 10593314
    [No Abstract]   [Full Text] [Related]  

  • 17. Lessons from hormone replacement therapy trials for primary prevention of cardiovascular disease.
    Mohandas B; Mehta JL
    Curr Opin Cardiol; 2007 Sep; 22(5):434-42. PubMed ID: 17762545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The changing view of hormone replacement therapy.
    Vogel RA
    Rev Cardiovasc Med; 2003; 4(2):68-71. PubMed ID: 12776015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focus on cardiovascular health: hormone replacement therapy, estrogen replacement therapy, and selective estrogen receptor modulators.
    Walsh BW
    J Am Osteopath Assoc; 2003 Feb; 103(2 Suppl 2):S6-8. PubMed ID: 12625632
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of coronary heart disease in post-menopausal women.
    Cullen P; von Eckardstein A; Barrett-Connor E; Lewis B; Mancini M; Riesen W; Schober O; Fruchart JC; Schwandt P; Assmann G;
    Nutr Metab Cardiovasc Dis; 2000 Oct; 10(5):267-74. PubMed ID: 11213536
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.